Technical Analysis for CNSP - CNS Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 2.02 -0.98% -0.02
CNSP closed down 0.98 percent on Monday, April 19, 2021, on 60 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CNSP trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -0.98%
Pocket Pivot Bullish Swing Setup -0.98%
Wide Bands Range Expansion -0.98%
Oversold Stochastic Weakness -0.98%
200 DMA Resistance Bearish -0.49%
Wide Bands Range Expansion -0.49%
Older End-of-Day Signals for CNSP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 12 hours ago
200 DMA Resistance about 12 hours ago
10 DMA Resistance about 12 hours ago
Outside Day about 12 hours ago
Down 5% about 12 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Oncology Blastoma Stage Pharmaceutical Glioblastoma Brain Tumor Central Nervous System Tumors Evofosfamide

Is CNSP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.62
52 Week Low 1.59
Average Volume 848,163
200-Day Moving Average 2.17
50-Day Moving Average 2.70
20-Day Moving Average 2.31
10-Day Moving Average 2.17
Average True Range 0.19
ADX 15.72
+DI 18.05
-DI 23.90
Chandelier Exit (Long, 3 ATRs ) 2.66
Chandelier Exit (Short, 3 ATRs ) 2.48
Upper Bollinger Band 2.71
Lower Bollinger Band 1.90
Percent B (%b) 0.15
BandWidth 35.27
MACD Line -0.15
MACD Signal Line -0.13
MACD Histogram -0.0264
Fundamentals Value
Market Cap 33.64 Million
Num Shares 16.7 Million
EPS -0.27
Price-to-Earnings (P/E) Ratio -7.42
Price-to-Sales 0.00
Price-to-Book 16.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.53
Resistance 3 (R3) 2.55 2.39 2.44
Resistance 2 (R2) 2.39 2.26 2.38 2.42
Resistance 1 (R1) 2.21 2.18 2.13 2.19 2.39
Pivot Point 2.05 2.05 2.02 2.05 2.05
Support 1 (S1) 1.87 1.92 1.79 1.85 1.65
Support 2 (S2) 1.71 1.84 1.71 1.62
Support 3 (S3) 1.53 1.71 1.60
Support 4 (S4) 1.51